,address1,city,state,zip,country,phone,fax,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,exDividendDate,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,pegRatio,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,1538 Main North Road,Salisbury South,SA,5106,Australia,61 8 8209 2666,61 8 8281 0284,https://www.maynepharma.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.","{'maxAge': 1, 'name': ""Mr. Shawn Patrick O'Brien B.Sc"", 'title': 'CEO, MD & Director', 'exercisedValue': 0, 'unexercisedValue': 0}",6,2,9,7,5,1693526400,1577750400,86400,4,3.37,3.4,3.36,3.47,3.37,3.4,3.36,3.47,1674000000,0.0,1.149024,-5.2575755,255367,255367,217127,227214,227214,3.4,3.47,0,0,295207840,2.68,6.4,1.6080085,4.3922,3.9534,0.0,0.0,AUD,108495528,0.63866,60074767,85074304,0.21235001,0.19929,85074304,7.604,0.45633876,1688083200,1719705600,1688083200,-317351008,-3.76,-0.66,0.43,1:20,1674000000,0.591,-0.908,-0.38035715,0.14113986,0.544,1673913600,ASX,EQUITY,MYX.AX,MYX.AX,M PHARMA FPO,Mayne Pharma Group Limited,1183075200,Australia/Sydney,AEST,b2f43747-c22c-3cca-a1bc-5d2d608d4066,finmb_28606250,36000000,3.47,3.8,2.68,3.24,3.24,3.5,hold,2,220142000,2.639,-119544000,47505000,1.382,1.78,183586000,7.489,2.231,-0.09192,-0.53285,83487000,-87635872,-42712000,-0.639,0.45476002,-0.65116,-1.01557,AUD,
1,1538 Main North Road,Salisbury South,SA,5106,Australia,61 8 8209 2666,61 8 8281 0284,https://www.maynepharma.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.","{'maxAge': 1, 'name': 'Mr. Aaron  Gray', 'title': 'Chief Financial Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",6,2,9,7,5,1693526400,1577750400,86400,4,3.37,3.4,3.36,3.47,3.37,3.4,3.36,3.47,1674000000,0.0,1.149024,-5.2575755,255367,255367,217127,227214,227214,3.4,3.47,0,0,295207840,2.68,6.4,1.6080085,4.3922,3.9534,0.0,0.0,AUD,108495528,0.63866,60074767,85074304,0.21235001,0.19929,85074304,7.604,0.45633876,1688083200,1719705600,1688083200,-317351008,-3.76,-0.66,0.43,1:20,1674000000,0.591,-0.908,-0.38035715,0.14113986,0.544,1673913600,ASX,EQUITY,MYX.AX,MYX.AX,M PHARMA FPO,Mayne Pharma Group Limited,1183075200,Australia/Sydney,AEST,b2f43747-c22c-3cca-a1bc-5d2d608d4066,finmb_28606250,36000000,3.47,3.8,2.68,3.24,3.24,3.5,hold,2,220142000,2.639,-119544000,47505000,1.382,1.78,183586000,7.489,2.231,-0.09192,-0.53285,83487000,-87635872,-42712000,-0.639,0.45476002,-0.65116,-1.01557,AUD,
2,1538 Main North Road,Salisbury South,SA,5106,Australia,61 8 8209 2666,61 8 8281 0284,https://www.maynepharma.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.","{'maxAge': 1, 'name': 'Ms. Kimberly  Parker J.D.', 'title': 'Exec. VP & Gen. Counsel', 'exercisedValue': 0, 'unexercisedValue': 0}",6,2,9,7,5,1693526400,1577750400,86400,4,3.37,3.4,3.36,3.47,3.37,3.4,3.36,3.47,1674000000,0.0,1.149024,-5.2575755,255367,255367,217127,227214,227214,3.4,3.47,0,0,295207840,2.68,6.4,1.6080085,4.3922,3.9534,0.0,0.0,AUD,108495528,0.63866,60074767,85074304,0.21235001,0.19929,85074304,7.604,0.45633876,1688083200,1719705600,1688083200,-317351008,-3.76,-0.66,0.43,1:20,1674000000,0.591,-0.908,-0.38035715,0.14113986,0.544,1673913600,ASX,EQUITY,MYX.AX,MYX.AX,M PHARMA FPO,Mayne Pharma Group Limited,1183075200,Australia/Sydney,AEST,b2f43747-c22c-3cca-a1bc-5d2d608d4066,finmb_28606250,36000000,3.47,3.8,2.68,3.24,3.24,3.5,hold,2,220142000,2.639,-119544000,47505000,1.382,1.78,183586000,7.489,2.231,-0.09192,-0.53285,83487000,-87635872,-42712000,-0.639,0.45476002,-0.65116,-1.01557,AUD,
3,1538 Main North Road,Salisbury South,SA,5106,Australia,61 8 8209 2666,61 8 8281 0284,https://www.maynepharma.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.","{'maxAge': 1, 'name': 'Mr. Brant  Schofield', 'age': 56, 'title': 'Exec. VP of Corp. Devel.', 'yearBorn': 1966, 'fiscalYear': 2019, 'totalPay': 1037502, 'exercisedValue': 0, 'unexercisedValue': 0}",6,2,9,7,5,1693526400,1577750400,86400,4,3.37,3.4,3.36,3.47,3.37,3.4,3.36,3.47,1674000000,0.0,1.149024,-5.2575755,255367,255367,217127,227214,227214,3.4,3.47,0,0,295207840,2.68,6.4,1.6080085,4.3922,3.9534,0.0,0.0,AUD,108495528,0.63866,60074767,85074304,0.21235001,0.19929,85074304,7.604,0.45633876,1688083200,1719705600,1688083200,-317351008,-3.76,-0.66,0.43,1:20,1674000000,0.591,-0.908,-0.38035715,0.14113986,0.544,1673913600,ASX,EQUITY,MYX.AX,MYX.AX,M PHARMA FPO,Mayne Pharma Group Limited,1183075200,Australia/Sydney,AEST,b2f43747-c22c-3cca-a1bc-5d2d608d4066,finmb_28606250,36000000,3.47,3.8,2.68,3.24,3.24,3.5,hold,2,220142000,2.639,-119544000,47505000,1.382,1.78,183586000,7.489,2.231,-0.09192,-0.53285,83487000,-87635872,-42712000,-0.639,0.45476002,-0.65116,-1.01557,AUD,
4,1538 Main North Road,Salisbury South,SA,5106,Australia,61 8 8209 2666,61 8 8281 0284,https://www.maynepharma.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.","{'maxAge': 1, 'name': 'Ms. Erinn  Nathaniel', 'title': 'Director of Global HR', 'exercisedValue': 0, 'unexercisedValue': 0}",6,2,9,7,5,1693526400,1577750400,86400,4,3.37,3.4,3.36,3.47,3.37,3.4,3.36,3.47,1674000000,0.0,1.149024,-5.2575755,255367,255367,217127,227214,227214,3.4,3.47,0,0,295207840,2.68,6.4,1.6080085,4.3922,3.9534,0.0,0.0,AUD,108495528,0.63866,60074767,85074304,0.21235001,0.19929,85074304,7.604,0.45633876,1688083200,1719705600,1688083200,-317351008,-3.76,-0.66,0.43,1:20,1674000000,0.591,-0.908,-0.38035715,0.14113986,0.544,1673913600,ASX,EQUITY,MYX.AX,MYX.AX,M PHARMA FPO,Mayne Pharma Group Limited,1183075200,Australia/Sydney,AEST,b2f43747-c22c-3cca-a1bc-5d2d608d4066,finmb_28606250,36000000,3.47,3.8,2.68,3.24,3.24,3.5,hold,2,220142000,2.639,-119544000,47505000,1.382,1.78,183586000,7.489,2.231,-0.09192,-0.53285,83487000,-87635872,-42712000,-0.639,0.45476002,-0.65116,-1.01557,AUD,
5,1538 Main North Road,Salisbury South,SA,5106,Australia,61 8 8209 2666,61 8 8281 0284,https://www.maynepharma.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.","{'maxAge': 1, 'name': 'Mr. Daniel  Moore', 'title': 'Exec. VP of Commercial', 'exercisedValue': 0, 'unexercisedValue': 0}",6,2,9,7,5,1693526400,1577750400,86400,4,3.37,3.4,3.36,3.47,3.37,3.4,3.36,3.47,1674000000,0.0,1.149024,-5.2575755,255367,255367,217127,227214,227214,3.4,3.47,0,0,295207840,2.68,6.4,1.6080085,4.3922,3.9534,0.0,0.0,AUD,108495528,0.63866,60074767,85074304,0.21235001,0.19929,85074304,7.604,0.45633876,1688083200,1719705600,1688083200,-317351008,-3.76,-0.66,0.43,1:20,1674000000,0.591,-0.908,-0.38035715,0.14113986,0.544,1673913600,ASX,EQUITY,MYX.AX,MYX.AX,M PHARMA FPO,Mayne Pharma Group Limited,1183075200,Australia/Sydney,AEST,b2f43747-c22c-3cca-a1bc-5d2d608d4066,finmb_28606250,36000000,3.47,3.8,2.68,3.24,3.24,3.5,hold,2,220142000,2.639,-119544000,47505000,1.382,1.78,183586000,7.489,2.231,-0.09192,-0.53285,83487000,-87635872,-42712000,-0.639,0.45476002,-0.65116,-1.01557,AUD,
6,1538 Main North Road,Salisbury South,SA,5106,Australia,61 8 8209 2666,61 8 8281 0284,https://www.maynepharma.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.","{'maxAge': 1, 'name': 'Dr. Frank  Casty M.D.', 'title': 'Exec. VP & Global Chief Medical Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",6,2,9,7,5,1693526400,1577750400,86400,4,3.37,3.4,3.36,3.47,3.37,3.4,3.36,3.47,1674000000,0.0,1.149024,-5.2575755,255367,255367,217127,227214,227214,3.4,3.47,0,0,295207840,2.68,6.4,1.6080085,4.3922,3.9534,0.0,0.0,AUD,108495528,0.63866,60074767,85074304,0.21235001,0.19929,85074304,7.604,0.45633876,1688083200,1719705600,1688083200,-317351008,-3.76,-0.66,0.43,1:20,1674000000,0.591,-0.908,-0.38035715,0.14113986,0.544,1673913600,ASX,EQUITY,MYX.AX,MYX.AX,M PHARMA FPO,Mayne Pharma Group Limited,1183075200,Australia/Sydney,AEST,b2f43747-c22c-3cca-a1bc-5d2d608d4066,finmb_28606250,36000000,3.47,3.8,2.68,3.24,3.24,3.5,hold,2,220142000,2.639,-119544000,47505000,1.382,1.78,183586000,7.489,2.231,-0.09192,-0.53285,83487000,-87635872,-42712000,-0.639,0.45476002,-0.65116,-1.01557,AUD,
7,1538 Main North Road,Salisbury South,SA,5106,Australia,61 8 8209 2666,61 8 8281 0284,https://www.maynepharma.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.","{'maxAge': 1, 'name': 'Mr. Brenton  Walter', 'title': 'Financial Controller', 'exercisedValue': 0, 'unexercisedValue': 0}",6,2,9,7,5,1693526400,1577750400,86400,4,3.37,3.4,3.36,3.47,3.37,3.4,3.36,3.47,1674000000,0.0,1.149024,-5.2575755,255367,255367,217127,227214,227214,3.4,3.47,0,0,295207840,2.68,6.4,1.6080085,4.3922,3.9534,0.0,0.0,AUD,108495528,0.63866,60074767,85074304,0.21235001,0.19929,85074304,7.604,0.45633876,1688083200,1719705600,1688083200,-317351008,-3.76,-0.66,0.43,1:20,1674000000,0.591,-0.908,-0.38035715,0.14113986,0.544,1673913600,ASX,EQUITY,MYX.AX,MYX.AX,M PHARMA FPO,Mayne Pharma Group Limited,1183075200,Australia/Sydney,AEST,b2f43747-c22c-3cca-a1bc-5d2d608d4066,finmb_28606250,36000000,3.47,3.8,2.68,3.24,3.24,3.5,hold,2,220142000,2.639,-119544000,47505000,1.382,1.78,183586000,7.489,2.231,-0.09192,-0.53285,83487000,-87635872,-42712000,-0.639,0.45476002,-0.65116,-1.01557,AUD,
8,1538 Main North Road,Salisbury South,SA,5106,Australia,61 8 8209 2666,61 8 8281 0284,https://www.maynepharma.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.","{'maxAge': 1, 'name': 'Ms. Laura  Loftus', 'title': 'Associate Gen. Counsel & Company Sec.', 'exercisedValue': 0, 'unexercisedValue': 0}",6,2,9,7,5,1693526400,1577750400,86400,4,3.37,3.4,3.36,3.47,3.37,3.4,3.36,3.47,1674000000,0.0,1.149024,-5.2575755,255367,255367,217127,227214,227214,3.4,3.47,0,0,295207840,2.68,6.4,1.6080085,4.3922,3.9534,0.0,0.0,AUD,108495528,0.63866,60074767,85074304,0.21235001,0.19929,85074304,7.604,0.45633876,1688083200,1719705600,1688083200,-317351008,-3.76,-0.66,0.43,1:20,1674000000,0.591,-0.908,-0.38035715,0.14113986,0.544,1673913600,ASX,EQUITY,MYX.AX,MYX.AX,M PHARMA FPO,Mayne Pharma Group Limited,1183075200,Australia/Sydney,AEST,b2f43747-c22c-3cca-a1bc-5d2d608d4066,finmb_28606250,36000000,3.47,3.8,2.68,3.24,3.24,3.5,hold,2,220142000,2.639,-119544000,47505000,1.382,1.78,183586000,7.489,2.231,-0.09192,-0.53285,83487000,-87635872,-42712000,-0.639,0.45476002,-0.65116,-1.01557,AUD,
